October is Breast Cancer Awareness Month NEW STUDY CONFIRMS EVEN MORE WOMEN WITH BREAST CANCER CAN SKIP CHEMOTHERAPY
Oct 18, 2021 ·
14m 34s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research expands the number of women with a common type of early stage breast cancer who can skip chemotherapy and safely be treated with hormone-blocking therapies alone – even...
show more
New research expands the number of women with a common type of early stage breast cancer who can skip chemotherapy and safely be treated with hormone-blocking therapies alone – even if their cancer has spread to some of their lymph nodes.[1] However, women whose tumors have spread to their lymph nodes are often at higher risk of worse outcomes, with the majority receiving chemotherapy.[2]
Results from the RxPONDER study, one of the largest clinical trials in hormone receptor-positive, HER2 negative early breast cancer, were presented at the San Antonio Breast Cancer Symposium in late 2020.1
Based on these new findings, postmenopausal women whose cancer has spread to between one and three lymph nodes can avoid the side effects associated with chemotherapy if their Oncotype DX Breast Recurrence Score® result, a genomic test which predicts chemotherapy benefit and risk of cancer recurrence, is between...
for video and more info go to https://goodnewsplanet.com/october-is-breast-cancer-awareness-month-new-study-confirms-even-more-women-with-breast-cancer-can-skip-chemotherapy/
##breast #cancer #chemotherapy #therapies #hormone #blocking #lymph #nodes #rxponder #menopausal #effects #oncotype #dx #recurrence #genomic #benefit #risk #exact
show less
Results from the RxPONDER study, one of the largest clinical trials in hormone receptor-positive, HER2 negative early breast cancer, were presented at the San Antonio Breast Cancer Symposium in late 2020.1
Based on these new findings, postmenopausal women whose cancer has spread to between one and three lymph nodes can avoid the side effects associated with chemotherapy if their Oncotype DX Breast Recurrence Score® result, a genomic test which predicts chemotherapy benefit and risk of cancer recurrence, is between...
for video and more info go to https://goodnewsplanet.com/october-is-breast-cancer-awareness-month-new-study-confirms-even-more-women-with-breast-cancer-can-skip-chemotherapy/
##breast #cancer #chemotherapy #therapies #hormone #blocking #lymph #nodes #rxponder #menopausal #effects #oncotype #dx #recurrence #genomic #benefit #risk #exact
Information
| Author | Paul Sladkus |
| Organization | Paul Sladkus |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments